This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, A.
Right arrow Articles by Netea, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, A.
Right arrow Articles by Netea, M. G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2008, p. 1407-1412, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.00155-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Drosomycin-Like Defensin, a Human Homologue of Drosophila melanogaster Drosomycin with Antifungal Activity{triangledown}

Anna Simon,1 Bart Jan Kullberg,1 Brian Tripet,6 Otto C. Boerman,2 Patrick Zeeuwen,3 Johanna van der Ven-Jongekrijg,1 Paul Verweij,4 Joost Schalkwijk,3 Robert Hodges,6 Jos W. M. van der Meer,1 and Mihai G. Netea1,5*

Departments of Medicine,1 Nuclear Medicine,2 Dermatology,3 Medical Microbiology, Radboud University Nijmegen Medical Center and Nijmegen University Center for Infectious Diseases, Nijmegen, The Netherlands,4 Divisions of Infectious Diseases,5 Biochemistry, University of Colorado Health Sciences Center, Denver, Colorado6

Received 1 February 2007/ Returned for modification 13 June 2007/ Accepted 23 November 2007

Innate antifungal defense in Drosophila melanogaster relies on the activation of the Toll molecule and the release of drosomycin, a defensin-like molecule with antifungal properties. Ten human homologues of Toll have been described, with central roles in activation of the innate host defense. In the present study, we report a putative human homologue of the Drosophila-derived drosomycin, designated drosomycin-like defensin (DLD). Synthetic DLD displays a broad spectrum of activity against Aspergillus spp. and other clinically relevant filamentous fungi. These effects are specific for filamentous fungi; no activity has been found against yeasts or gram-positive or gram-negative bacteria. Synthetic DLD also displays immunomodulatory effects on Aspergillus-stimulated cytokine production. In addition, we show the expression of DLD mRNA in several human tissues, particularly in the skin, consistent with its putative role as a defensin against invading microorganisms. This is the first indication of an endogenous human peptide with specific antifungal activity, which is probably central in the defense against infections with molds.

* Corresponding author. Mailing address: Department of Medicine (463), Radboud University Nijmegen Medical Center, Geert Grooteplein 8, 6500 HB, Nijmegen, The Netherlands. Phone: 31-24-3618819. Fax: 31-24-3541734. E-mail: m.netea{at}aig.umcn.nl

{triangledown} Published ahead of print on 22 January 2008.

Antimicrobial Agents and Chemotherapy, April 2008, p. 1407-1412, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.00155-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Chamilos, G., Lewis, R. E., Hu, J., Xiao, L., Zal, T., Gilliet, M., Halder, G., Kontoyiannis, D. P. (2008). Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc. Natl. Acad. Sci. USA 105: 9367-9372 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»